TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING ROTIGOTINE AND AT LEAST ONE NON-AMINE-RESISTANT SILICONE ADHESIVE

The invention relates to a transdermal therapeutic system (TTS) for the administration of the active ingredient rotigotine comprising a matrix layer containing rotigotine, one or more non-amine-resistant silicone adhesives in an amount of more than 50% by weight, based on the total weight of the pre...

Full description

Saved in:
Bibliographic Details
Main Authors WAUER, GABRIEL, BENDA, CHRISTIAN, SCHURAD, BJÖRN, KOLLING, ULRIKE
Format Patent
LanguageEnglish
Polish
Published 26.02.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a transdermal therapeutic system (TTS) for the administration of the active ingredient rotigotine comprising a matrix layer containing rotigotine, one or more non-amine-resistant silicone adhesives in an amount of more than 50% by weight, based on the total weight of the pressure sensitive adhesive of the matrix layer, and paraffin, as well as methods for the preparation thereof. The transdermal therapeutic system according to the invention is particularly suitable for the treatment of the Parkinson disease.
Bibliography:Application Number: PL20200153621T